Maintaining validity of neuropathic pain screening tools over time: challenges and opportunities

Giulia Mesaroli, Anthony V. Perruccio, Kristen M. Davidge, Jennifer Stinson · 2026

Read Maintaining validity of neuropathic pain screening tools over time: challenges and opportunities by Giulia Mesaroli, Anthony V. Perruccio, Kristen M. Davidge, Jennifer Stinson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13457814.txt.

Description

Giulia Mesaroli and colleagues warn that nerve pain screening tools can go stale as definitions change in a 2026 review. Screening tools are usually validated once at birth, yet neuropathic pain has since been redefined, reclassified and rediagnosed, which can quietly erode a tool's meaning. The review searched systematically for content and criterion validity studies of the Leeds Assessment of Neuropathic Symptoms and Signs, judging content against COSMIN standards and criterion work against QUADAS-2.

Twelve papers qualified, but patient-based content evidence was thin and two items may no longer fit nerve pain at face value. Six criterion studies may no longer apply because their patients or diagnostic methods are outdated, while the other six varied wildly, with sensitivity from 22 to 86 percent. The authors urge fresh content testing and possible revision, treating validation as an ongoing duty rather than a one-time stamp.

Catalog record

CREATORGiulia Mesaroli, Anthony V. Perruccio, Kristen M. Davidge, Jennifer Stinson
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13457814

Browse the full library · About the Tower of Babel